Background: Intracranial stenting is still feasible, but its effectiveness is still investigational. Our study investigated outcomes of endovascular treatment in high-volume and low-volume centers. Methods: We retrospectively recruited 36 patients with intracranial atherosclerosis underwent endovascular treatment from January 2014 to June 2016 at three low-volume centres (n=18), and a single high-volume centre (n=18). Detailed periprocedural records, clinical and radiological follow-up data were revised through at least one year after the procedure. Outcome parameters included successful revascularization, occurrence of any death, stroke, and/or Transient Ischaemic Attack (TIA) after intervention or during follow-up period, and restenosis (≥ 50%). Results: Successful revascularization rate was 97.2%. The 30-days rate of any death, stroke, and/or TIA was 13.9%. At median clinical follow-up of 18-month, rate of any death, stroke, and/or TIA was 27.8%. Rates of any death, stroke, and/or TIA at 30-days and 18-month were higher among patients treated in low-volume centre versus those treated in high-volume centre but without reaching statistical significance (22.2% versus 5.6%, p = 0.188; and 38.9% versus 16.7%, p = 0.137, respectively). Conclusions: Although not statistically significant, our study showed higher incidence of death, stroke and/or TIA among patients treated in low-volume center compared to those treated in high-volume center.
(1) Background: Persistent post-COVID-19 headaches are emerging as a significant post-infection symptom. This study investigates the clinical characteristics of persistent post-COVID-19 headaches and the potential role of pro-inflammatory cytokines. (2) Methods: We conducted a pilot case–control study involving 84 participants divided into three groups: post-COVID with headache (n = 28), post-COVID without headache (n = 28), and healthy controls (n = 28). The detailed headache characteristics, including pain intensity, were assessed using the Visual Analog Scale (VAS). The serum levels of inflammatory cytokines (IL-6 and TNF-α) were measured. (3) Results: Post-COVID headaches predominantly presented as bilateral (53.6%) and throbbing (60.7%) in nature, with a median of 12 headache days per month and high pain intensity (median VAS score = 80). The associated symptoms were phonophobia (85.7%), fatigue (78.6%), and photophobia (75%). The serum levels of IL-6 and TNF-α were significantly higher in post-COVID headache patients than in the post-COVID without headache and healthy control groups (p < 0.001). A Receiver Operating Characteristic analysis showed that the circulating levels of IL-6 and TNF-α could discriminate our study groups at cutoffs with variable sensitivity and specificity. (4) Conclusions: Persistent post-COVID-19 headaches have diverse clinical characteristics and are associated with elevated circulating levels of pro-inflammatory cytokines, suggesting a potential underlying neuroinflammation.
Background: Intracranial stenting is still feasible, but its effectiveness is still investigational. Our study investigated outcomes of endovascular treatment in high-volume and low-volume centres. Methods: We retrospectively recruited 36 patients with intracranial atherosclerosis who underwent endovascular treatment from January 2014 to June 2016 at three low-volume centres (n = 18), and a single high-volume centre (n = 18). Detailed periprocedural records, as well as clinical and radiological follow-up data, were revised through at least one-year post-procedure. The outcome parameters included successful revascularization, occurrence of any death, stroke, and/or Transient Ischaemic Attack (TIA) after intervention or during the follow-up period, and restenosis (≥50%). Results: The successful revascularization rate was 97.2%. The 30-day rate of any death, stroke, and/or TIA was 13.9%. At a median clinical follow-up of 18 months, the rate of any death, stroke, and/or TIA was 27.8%. Rates of any death, stroke, and/or TIA at 30 days and 18 months were higher among patients treated in low-volume centres versus those treated in high-volume centres but without reaching statistical significance (22.2% versus 5.6%, p = 0.188; and 38.9% versus 16.7%, p = 0.137, respectively). Conclusions: Although not statistically significant, our study showed a higher incidence of death, stroke and/or TIA among patients treated in the low-volume centre compared to those treated in the high-volume centre.
30 June 2024 in Pakistan Journal of Neurological Sciences
Background and Objective: Stroke remains a leading cause of mortality and long-term disability worldwide, with significant socioeconomic implications. This study aimed to investigate gender-based differences in acute stroke patients regarding baseline characteristics, clinical presentation, and predictors of poor outcome in an Egyptian population. Methods: We prospectively recruited 116 acute stroke patients admitted to the stroke unit at Cairo University Hospitals from January to June 2020. Detailed data on demographics, clinical characteristics, diagnostic workup, hospital course, and functional outcomes were collected. Poor outcome was defined as a modified Rankin Scale (mRS) ≥ 3 at discharge. Data were analyzed using SPSS version 28 (IBM Corp., Armonk, NY, USA). Results: The study included 60 males (51.7%) and 56 females (48.3%) with a median age of 62 years. Atrial fibrillation (32.1% vs 15%, p = 0.029) and obesity (80.3% vs 66.7%, p = 0.010) were more common in females, while smoking history was more common in males (70% vs 7.1%, p < 0.001). Females had higher levels of total cholesterol (median 238 vs 189 mg/dL, p = 0.007) and triglycerides (median 160 vs 141 mg/dL, p = 0.026). Using regression analysis, dysphagia remained an independent predictor of poor outcome in both females (OR : 23.4, 95% CI : 2.521-217.2, p=0.006) and males (OR : 15.769, 95% CI : 1.686-147.509, p=0.016). Conclusion: This pilot study highlights important gender differences in stroke charachteristics and emphasizes the need for a wide-scale stroke registry in Egypt. The strong association between dysphagia and poor outcomes in both genders highlights the importance of early dysphagia screening and management in acute stroke care.